Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...
The licensing deal will see American pharma company ARS retain the rights for the needle-free treatment for anaphylaxis in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback